SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 190.96-2.1%12:03 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bob zagorin who wrote (23873)8/4/1998 3:20:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
bob, I checked with LGND IR today, and it doesn't sound like LGND was directly affected by changes a T. Rowe Price. The family of funds has owned quite a bit of LGND for some time now and there has been little change in their position over the past several months. As I posted previously, at the end of last year's 3Q they held over 400,000 shares of LGND. As of a few weeks ago, their holdings were even higher.

The WSJ article confirmed what I had heard elsewhere. The big boys are pulling out of the smaller Biotechs. Companies like LGND, with products in late stages of development should eventually benefit, although at this time the Biotech glass clearly has a "half empty" look.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext